High expression of podoplanin is associated with shorter overall survival in CTCL patients, and the expression levels of vascular and proliferative markers correlate in situ (Jankowska-Konsur et al., 2016, 2017). Here, PDPN is linked to primary cutaneous T-cell non-Hodgkin lymphoma.